Sarepta Therapeutics Balance Sheet - Annual (NASDAQ:SRPT)

Add to My Stocks
$36.26 $1.54 (4.44%) SRPT stock closing price Apr 28, 2017 (Closing)

The Sarepta Therapeutics balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Sarepta Therapeutics stock analysis. A company releases its balance sheet every quarter along with its quarterly results. The Sarepta Therapeutics balance sheet for 2016 shows total assets of $424.1M. Sarepta Therapeutics revenue was $5.42M and Sarepta Therapeutics operating cash flow was $-245.82M for the same year. View latest and last 10 year balance sheet data to check Sarepta Therapeutics financial performance..

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Marketable Securities206.12M122.88M136.79M7.25M---0.17M0.28M0.27M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets26.89M17.38M35.03M3.06M1.53M1.64M1.02M0.77M0.59M0.76M
Sarepta Therapeutics Total Current Assets
Property Plant & Equipment68.14M61.93M58.39M32.37M20.1M20.03M17.03M16.49M18.1M18.64M
Accumulated Depreciation30.34M24.59M19.89M17.32M16.7M15.76M14.96M14.02M12.91M11.81M
Sarepta Therapeutics Net Property Plant & Equipment
Investment & Advances0.78M0.78M0.78M0.64M------
Other Non-Current Assets------1.96M2.37M--
Deferred Charges---------3.06M
Deposits & Other Assets3.96M4.47M2.06M0.02M2.77M0.15M0.12M0.12M0.03M0.03M
Sarepta Therapeutics Total Assets
Notes Payable-2.49M2.49M-------
Accounts Payable29.69M20.23M12.4M17.63M7.53M9.39M1.31M1.38M2.01M3.02M
Current Portion Long-Term Debt10.1M5.93M0.09M0.09M0.08M0.08M0.08M0.07M0.07M0.07M
Current Portion Capital Leases----------
Accrued Expenses31.01M29.05M17.36M5.04M2.74M2.24M2.01M0.92M1.3M1.17M
Income Taxes Payable----------
Other Current Liabilities4.6M4.57M4.5M13.19M68.52M8.87M42.45M31.12M3.89M5.48M
Sarepta Therapeutics Total Current Liabilities
Deferred Taxes/Income5.94M6.17M6.77M6.83M------
Convertible Debt----------
Long-Term Debt6.04M14.96M3.73M1.57M1.66M1.75M1.84M1.92M2M2.07M
Non-Current Capital Leases----------
Other Long-Term Liabilities----0.76M0.99M1.09M0.96M0.51M0.43M
Sarepta Therapeutics Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.01M0.01M---0.01M0.01M0.01M0.01M0.01M
Capital Surplus1.5B1.09B926.76M790.42M554.92M340.96M304.81M299.08M266.03M252.73M
Retained Earnings-1.17B-899.05M-679.02M-543.23M-431.25M-309.96M-307.64M-275.46M-250.31M-226.35M
Treasury Stock----------
Other Liabilities-0.12M-0.11M-0.09M-------
Sarepta Therapeutics Shareholders Equity
Sarepta Therapeutics Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Balance sheet for another ticker

Most investors just check the Sarepta Therapeutics stock price, and Sarepta Therapeutics historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Sarepta Therapeutics PE ratio chart. Below is a brief explanation of common balance sheet terms:
  • Assets: An asset is a resource that a corporation like Sarepta Therapeutics owns and has monetary significance. SRPT assets grew from $273.78M in 2015 to $424.1M in 2016 . Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. SRPT stock had total liabilities of $87.41M for year 2016.

Sarepta Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover

Annual Balance Sheets For Sarepta Therapeutics Inc Peers

Aviragen Therapeutics balance sheet, BioCryst Pharma balance sheet, Blueprint Medicines balance sheet, Gilead Sciences balance sheet, Halozyme Therapeutics balance sheet